Moody's: Outlook For Global Pharmaceuticals Stable Despite Growing Anger
Moody’s expects global pharmaceuticals to be stable in 2017, as cost pressures neutralize gains from rising demand, and modest price increases in U.S. offset single-digit declines in rest of the world and despite growing anger over increasing drug costs. The outlook for the medical device industry and for-profit hotel chains was also rated stable.
Healthcare will account for a larger share of GDP in most countries, as demographics, including aging populations, continue to . . .
SORRY! This content is exclusively for paying members. If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.
|
